Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.
If you have any suggestions for future topics for the newsletter, then please contact email@example.com
This month’s edition covers how the RDTC can support stakeholder organisations, our recent publications, and the prescribing support workplan. It also has features on post exposure prophylaxis for chickenpox and shingles, the national flu immunisation programme 2022-23, inadvertent oral administration of potassium permanganate, the CVD eLearning programme, WHO changes to the treatment of drug-resistant tuberculosis, and sources of information on menopause and HRT availability.
Each year the RDTC considers the information published in the SPS Prescribing Outlook series, and from this information highlights developments that are likely to have significant impact on primary care prescribing budgets, over the coming 12 – 15 months.
The RDTC takes the SPS Cost Calculator and aids in filters to calculate totals for each of its stakeholder ICS and CCGs.
A Key Considerations Document accompanies the Cost Calculator detailing the key messages, summarising the current prescribing budget position, and suggesting proposed uplifts to prescribing budgets for the next financial year.
This is supplemented throughout the year with the RDTC Monthly Horizon Scanning series, which provides a more accurate monthly account of the impact of new medicines and recommendations as they publish.
There are five regional versions of this publication. These can all be found on the Annual Horizon Scanning Report page
Monthly Formulary Amendments Documents are a series of new publications from the RDTC for its Stakeholders. These monthly reports list any NICE Technology Appraisals, NICE Guidelines, RMOC Guidance, MHRA Drug Safety Updates, and National Patient Safety Alerts published in the previous calendar month which may have an impact on local formularies and guidelines. This document is for APCs, and formulary committees to ensure formularies remain up to date, and in line with latest NICE guidance and safety information.
It includes a suggested formulary position for APCs/Formulary Committees, together with a summary of any financial/commissioning implications. The purpose of the document is to support consistent decision making by APCs.
This information is produced for use by NHS healthcare professionals and RDTC stakeholders.
These can all be found on the Formulary amendments page